Global Circular RNA Research Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Circular RNA Research Market Research Report 2024
Circular RNA is a type of single-stranded RNA molecule with a special structure, which widely exists in different organisms. Unlike the classic linear RNA (linear RNA), circular RNA molecules have no 5' and 3' ends and are in a closed circular structure. Therefore it is not affected by RNA exonucleases and is more stable in vivo. It is a popular target for the treatment of human diseases. Its application potential is very great, and it has opened up a new idea for the field of biomedicine. Circular RNAs with clear functions can be used not only as biomarkers for the diagnosis of certain diseases, but also as therapeutic targets for some important diseases, especially immune diseases and cancers. They are widely used in infectious diseases, rare diseases, The treatment of blood diseases and tumors has both research and application value.
According to MRAResearch’s new survey, global Circular RNA Research market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Circular RNA Research market research.
Key companies engaged in the Circular RNA Research industry include Laronde, Orna Therapeutics, Chimerna Therapeutics, Shanghai Circode, Therorna Inc., Beijing Abace Biology, BGI TechSolutions Co.,Ltd. (BGI-Tech), Shanghai Cloudseq and Guangzhou Geneseed Biotech Co.,Ltd., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Circular RNA Research were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Circular RNA Research market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Circular RNA Research market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Laronde
Orna Therapeutics
Chimerna Therapeutics
Shanghai Circode
Therorna Inc.
Beijing Abace Biology
BGI TechSolutions Co.,Ltd. (BGI-Tech)
Shanghai Cloudseq
Guangzhou Geneseed Biotech Co.,Ltd.
Segment by Type
ecircRNA Research
ciRNA Research
ElciRNA Research
Other
Research & Academic Institutes
Pharma & Biotech Companies
CROs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Circular RNA Research report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Circular RNA Research market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Circular RNA Research market research.
Key companies engaged in the Circular RNA Research industry include Laronde, Orna Therapeutics, Chimerna Therapeutics, Shanghai Circode, Therorna Inc., Beijing Abace Biology, BGI TechSolutions Co.,Ltd. (BGI-Tech), Shanghai Cloudseq and Guangzhou Geneseed Biotech Co.,Ltd., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Circular RNA Research were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Circular RNA Research market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Circular RNA Research market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Laronde
Orna Therapeutics
Chimerna Therapeutics
Shanghai Circode
Therorna Inc.
Beijing Abace Biology
BGI TechSolutions Co.,Ltd. (BGI-Tech)
Shanghai Cloudseq
Guangzhou Geneseed Biotech Co.,Ltd.
Segment by Type
ecircRNA Research
ciRNA Research
ElciRNA Research
Other
Segment by Application
Research & Academic Institutes
Pharma & Biotech Companies
CROs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Circular RNA Research report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source